Author:
Tsimberidou Apostolia-Maria,Lewis Nancy,Reid Tony,Burris Howard,Urban Patrick,Tan Eugene Y.,Anand Suraj,Uehara Cynthia,Kurzrock Razelle
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference18 articles.
1. (2010) Omeprazole prescribing information. AstraZeneca LP, Wilmington
2. Abrey LE, Wen P, Govindan R, Reimers H, Rigas JR, Robins HI, Allen-Freda E, Gao B, Ko J, Johri A (2008) Patupilone for the treatment of recurrent/progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): an open-label phase II study. J Clin Oncol 26:15 s (suppl; abstr 2033)
3. Altmann KH, Wartmann M, O’Reilly T (2000) Epothilones and related structures—a new class of microtubule inhibitors with potent in vivo antitumor activity. Biochim Biophys Acta 1470:M79–M91
4. Beardsley EK, Saad F, Eigl B, Venner P, Hotte S, Winquist E, Ko YJ, Sridhar SS, Chi KN (2009) A phase II study of patupilone in patients (pts) with metastatic castration—resistant prostate cancer (CRPC) who have progressed after docetaxel. J Clin Oncol 27:15 s (suppl; abstr 5139)
5. Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55:2325–2333
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献